ZA200807034B - Immunomodulatory and anti-tumour peptides - Google Patents

Immunomodulatory and anti-tumour peptides

Info

Publication number
ZA200807034B
ZA200807034B ZA200807034A ZA200807034A ZA200807034B ZA 200807034 B ZA200807034 B ZA 200807034B ZA 200807034 A ZA200807034 A ZA 200807034A ZA 200807034 A ZA200807034 A ZA 200807034A ZA 200807034 B ZA200807034 B ZA 200807034B
Authority
ZA
South Africa
Prior art keywords
immunomodulatory
tumour peptides
tumour
peptides
Prior art date
Application number
ZA200807034A
Other languages
English (en)
Inventor
Guerra Vallespi Maribel
Carmen Torrens Madrazo Isis Del
Reyes Acosta Osvaldo
Garay Perez Hilda Elisa
Guillen Nieto Gerardo Enrique
Acevedo Castro Boris Ernesto
Ubieta Gomez Raimundo
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of ZA200807034B publication Critical patent/ZA200807034B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200807034A 2006-02-24 2008-08-14 Immunomodulatory and anti-tumour peptides ZA200807034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20060047A CU23582A1 (es) 2006-02-24 2006-02-24 Péptidos con capacidad anti-tumoral e inmunomoduladora

Publications (1)

Publication Number Publication Date
ZA200807034B true ZA200807034B (en) 2009-06-24

Family

ID=38123823

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807034A ZA200807034B (en) 2006-02-24 2008-08-14 Immunomodulatory and anti-tumour peptides

Country Status (16)

Country Link
US (1) US8283324B2 (enExample)
EP (1) EP1992638B1 (enExample)
JP (1) JP5069250B2 (enExample)
KR (1) KR101456205B1 (enExample)
CN (1) CN101426813B (enExample)
AR (1) AR059608A1 (enExample)
AT (1) ATE493434T1 (enExample)
AU (1) AU2007218671B2 (enExample)
BR (1) BRPI0708148B1 (enExample)
CA (1) CA2638828C (enExample)
CU (1) CU23582A1 (enExample)
ES (1) ES2358845T3 (enExample)
MX (1) MX2008010893A (enExample)
RU (1) RU2430109C2 (enExample)
WO (1) WO2007095867A1 (enExample)
ZA (1) ZA200807034B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23674A1 (es) * 2007-07-31 2011-05-27 Ct Ingenieria Genetica Biotech Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica
EP2108372A1 (en) 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Novel antimicrobial peptides
ES2655687T3 (es) * 2009-09-11 2018-02-21 Proyecto De Biomedicina Cima, S.L. Composiciones terapéuticas para el tratamiento de enfermedades causadas por HPV
CU23897B1 (es) * 2010-05-31 2013-05-31 Ct De Ingeniería Genética Y Biotecnología Péptido para la terapia del cáncer
CN103724412A (zh) * 2013-09-29 2014-04-16 中国科学院海洋研究所 中国明对虾抗脂多糖因子及其制备和应用
CA3260155A1 (en) * 2022-06-29 2024-01-04 Cdres Pharma Llc Immunologically active polypeptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0664814A1 (en) 1993-08-18 1995-08-02 MorphoSys AG Lipopolysaccharide-binding and neutralizing peptides
CU22700A1 (es) * 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
AU2002214876A1 (en) 2000-11-08 2002-05-21 Lorus Therapeutics Inc. Combination preparation of a biological response modifier and an anticancer agent and uses thereof

Also Published As

Publication number Publication date
WO2007095867A1 (es) 2007-08-30
CA2638828C (en) 2014-09-09
CA2638828A1 (en) 2007-08-30
CU23582A1 (es) 2010-10-30
JP5069250B2 (ja) 2012-11-07
AR059608A1 (es) 2008-04-16
ES2358845T3 (es) 2011-05-16
EP1992638B1 (en) 2010-12-29
AU2007218671B2 (en) 2012-02-09
RU2008137968A (ru) 2010-03-27
US8283324B2 (en) 2012-10-09
JP2009527510A (ja) 2009-07-30
RU2430109C2 (ru) 2011-09-27
AU2007218671A1 (en) 2007-08-30
CN101426813A (zh) 2009-05-06
KR101456205B1 (ko) 2014-10-31
US20090221508A1 (en) 2009-09-03
BRPI0708148A2 (pt) 2011-05-17
CN101426813B (zh) 2012-04-04
MX2008010893A (es) 2008-09-03
BRPI0708148B1 (pt) 2019-01-15
EP1992638A1 (en) 2008-11-19
KR20080106446A (ko) 2008-12-05
ATE493434T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
GB0712670D0 (en) Isolated peptides and uses thereof
PL2061886T3 (pl) Małe kationowe peptydy immunomodulujące
ZA200810323B (en) Fkbp-l and uses thereof
GB0702020D0 (en) Peptides and their use
LT2064327T (lt) Dbait ir jų panaudojimas
IL195663A0 (en) Covering and component parts thereof
ZA201001451B (en) Immunomodulatory peptides
GB0708376D0 (en) Novel polypeptides and uses thereof
EP2017283A4 (en) Peptides
ZA200903906B (en) Carboranylporphyrins and uses thereof
IL185308A0 (en) Replikin peptides and uses thereof
EP1976864A4 (en) NEW PEPTIDE AND ITS USE
GB0702021D0 (en) Peptides and their use
IL195525A0 (en) Replikin peptides and uses thereof
GB0702022D0 (en) Peptides and their use
ZA200807034B (en) Immunomodulatory and anti-tumour peptides
GB0621513D0 (en) Novel polypeptides and uses thereof
GB0604187D0 (en) Peptide and uses thereof
EP2197899B8 (fr) Peptides cycliques comprenant au moins un residu aza-beta-3 aminoacycle et leurs utilisations
PL2032708T3 (pl) Rekombinowane nowirabdowirusy i ich zastosowania
GB0618748D0 (en) Peptide
GB0708529D0 (en) Peptide standards
IL197675A0 (en) Peptides
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0605774D0 (en) Peptide